We are research driven pharmaceutical company who develop, manufacture and supply differentiated generic products in the oral solid dosage forms, both as pre-formulation intermediates as well as finished formulation for certain key therapeutic segments. We offer both pharmaceutical and nutraceutical products. We have in-house R&D capabilities to offer a range of non-infringing drug delivery solutions based on process technologies that bring patient compliance thereby reducing the cost of treatment.
$8.2M sweet spot round size
1989
$8.2M
from 1 investors over 1 rounds
ZIM LABORATORIES LIMITED raised $8.2M on February 3, 2013
Investors: Ashmore Alchemy